RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Photons behave very strangely if you try to cut them
4
Does gravity create reality? A shocking path to a theory of everything
5
Glaciers in the 'roof of the world' have suddenly started melting
6
Is a super El Niño imminent, and what could the impacts be?
7
Q-Day could destroy bitcoin – and our retirement savings
8
The late Ian Watson's sci-fi The Embedding is intriguing – but dated
9
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
10
Experimental mRNA vaccine may protect against multiple Ebola viruses
